RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets

O A Kent1, K Fox-Talbot, M K Halushka

  • 1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. kent@lunenfeld.ca

Oncogene
|July 4, 2012
PubMed

Insights

MicroRNAs miR-143 and miR-145 are underexpressed in colorectal cancer. The Ras responsive element binding protein 1 (RREB1) represses these microRNAs, offering a new therapeutic target for KRAS-driven colorectal tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • miR-143 and miR-145 are frequently downregulated in colorectal tumors.
  • Activating KRAS mutations are common in colorectal cancer, with an observed inverse correlation to miR-143/145 expression.
  • Oncogenic KRAS was previously shown to repress miR-143/145 in pancreatic cancer via RREB1.

Purpose of the Study:

  • To investigate the role of RREB1 in the repression of miR-143/145 in colorectal cancer.
  • To elucidate the regulatory network involving KRAS, RREB1, and miR-143/145 in colorectal adenocarcinoma.
  • To explore the therapeutic potential of miR-143/145 in modulating signaling pathways in colorectal cancer.

Main Methods:

  • Assessed RREB1 and miR-143/145 expression in colorectal tumors and cell lines.
  • Investigated the regulatory relationship between RREB1, KRAS, and miR-143/145 using colorectal cancer cell lines.
  • Utilized reporter assays to confirm RREB1's interaction with the miR-143/145 promoter.
  • Overexpressed miR-143 or miR-145 in HCT116 cells to analyze downstream signaling pathway modulation.

Main Results:

  • RREB1 is overexpressed in colorectal adenocarcinoma, inversely correlating with miR-143/145 primary transcript expression.
  • RREB1, activated by the MAPK pathway, represses the miR-143/145 promoter in colorectal cancer cell lines downstream of active KRAS.
  • Overexpression of miR-143/145 abrogated MAPK, PI3K, and JNK signaling by downregulating KRAS, RREB1, and other MAPK pathway genes.

Conclusions:

  • RREB1 acts as a key repressor of the miR-143/145 cluster in KRAS-driven colorectal cancer.
  • A complex regulatory network exists where miR-143/145 modulates KRAS signaling.
  • These findings highlight the miR-143/145 cluster as a potential therapeutic target in colorectal cancer treatment.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...